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Equipoise across the patient population:
optimising recruitment to a randomised
controlled trial
Paul Whybrow1,3* , Robert Pickard2, Susan Hrisos1 and Tim Rapley1
Abstract
Background: This paper proposes a novel perspective on the value of qualitative research for improving trial
design and optimising recruitment. We report findings from a qualitative study set within the OPEN trial, a surgical
randomised controlled trial (RCT) comparing two interventions for recurrent bulbar urethral stricture, a common
cause of urinary problems in men.
Methods: Interviews were conducted with men meeting trial eligibility criteria (n = 19) to explore reasons for
accepting or declining participation and with operating urologists (n = 15) to explore trial acceptability.
Results: Patients expressed various preferences and understood these in the context of relative severity and
tolerability of their symptoms. Accounts suggest a common trajectory of worsening symptoms with a particular
window within which either treatment arm would be considered acceptable. Interviews with clinician recruiters
found that uncertainty varied between general and specialist sites, which reflect clinicians’ relative exposure to
different proportions of the patient population.
Conclusion: Recruitment post referral, at specialist sites, was challenging due to patient (and clinician) expectations.
Trial design, particularly where there are fixed points for recruitment along the care pathway, can enable or constrain
the possibilities for effective accrual depending on how it aligns with the optimum point of patient equipoise.
Qualitative recruitment investigations, often focussed on information provision and patient engagement, may also
look to better understand the target patient population in order to optimise the point at which patients are approached.
Trial registration: ISRCTN Registry, ISRCTN98009168. Registered on 29 November 2012.
Keywords: Trials, Recruitment, Qualitative, Multicentre, Trial design, Surgical trial, Equipoise, Patient preferences
Background
About a half of all randomised controlled trials (RCTs)
face difficulties in achieving target recruitment [1].
Recruitment shortfall has ethical implications and comes
at considerable cost in terms of time and effort to the
patients and trialists, as well as wastage of patient data
and monetary loss. Recruitment and retention are widely
felt to be the most important factors for achieving a
successful trial [2, 3]. Nesting a qualitative study within
trials is seen as an effective method of improving
recruitment [4] but there is a lack of methodological and
theoretical articulation of how qualitative findings achieve
this. This paper reports findings from a qualitative study
embedded in the feasibility phase of the ‘Clarifying the
management of men with recurrent urethral stricture:
a pragmatic multicentre, randomised superiority trial
of open urethroplasty versus endoscopic urethrotomy
(OPEN)’ trial (www.opentrial.co.uk). The purpose of
the study was to improve trial recruitment by investi-
gating patient experience, clinicians’ perspectives and
overall trial process.
Qualitative research and trial recruitment
In the United Kingdom (UK) the National Institute of
Health Research (NIHR) recently set a target to see
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more patients and health professionals participating in
health research [5]. Trialists are challenged to reverse
the trend of poor participation through improved trial de-
sign and management. Qualitative studies have emerged
as key to addressing this challenge. A recent review found
that trials with a qualitative component were better
equipped to adapt to problems and increase recruitment
[4]. Embedded qualitative investigations are described as
the ‘most successful intervention’ to address poor recruit-
ment ([4]: 12). However, these studies can vary in quality
and depth and are often poorly reported [6]. Successful
implementation of qualitative findings requires that the
research is integrated within the trial, carried out by expe-
rienced qualitative researchers and develops robust con-
ceptual articulation of the data [7].
Donovan et al. have demonstrated the value of analysing
clinician and patient trial-orientated interactions, focus-
sing on recruitment activity, to improve patient infor-
mation and the recruitment process [8]. The way that
clinicians present the interventions, the need for ran-
domisation and study rationale has a significant impact
on whether eligible patients feel that participation is ac-
ceptable [9]. Trial recruitment is a fragile process as cli-
nicians may experience discomfort where their instinct
may be at odds with the community equipoise and re-
quire training and support to adjust [10]. Qualitative re-
search can be used to expose barriers hindering recruiters
from engaging productively with eligible patients [11, 12].
The most significant barrier to trial recruitment is pa-
tient preference for a specific treatment option [13–16].
A number of studies have explored why patients accept
or decline trial participation, revealing factors such as
forms of (conditional) altruism, a sense of involvement
or therapeutic misunderstandings [17, 18]. In practice,
patients’ preferences are complex and often trial-specific
[6, 19] so it is important that they are acknowledged by
recruiters and brought into an information exchange
[9, 12, 20].
As well as paying attention to clinician and patient
perspectives, it is also important to look at the congru-
ence of trial design and standard care pathways [21, 22].
Practical and contextual considerations often become
highly important to trial success such as needing to pro-
actively follow up participants [21]. Qualitative research
can have an evaluative role in identifying issues with the
trial design or poor enactment [23]. Treweek has pointed
out that trials often succeed or fail on the basis of early de-
sign decisions and calls for a better awareness of practical
design choices [21, 24].
The nature of qualitative research is situated and
context-driven, which means that its distinct value can
be difficult to pin down. Advocates refer to the ability to
‘explore complexity’, ‘identify barriers’ and understand
‘social contexts’ [4, 8], although it is difficult to provide
definitive guidelines. Trialists should be mindful of the
inability to explore all areas in a short period of time,
and focus on aspects most important to their trial [7]. In
this paper we build on these discussions using the findings
from our qualitative investigation of recruitment to the
OPEN trial, demonstrating how they informed changes to
the trial recruitment strategy. We suggest that there is
benefit in better understanding the patient population and
the conditions in which patients are in equipoise.
Equipoise and trial participation
The concept of equipoise is the ethical foundation for
recruiting patients into clinical trials. It has emerged
from the legal-moral discussions about the conditions
under which it is ethically permissible to randomise a
patient’s treatment as part of a clinical trial [25], the
concern being that recruiting to a trial may compromise
the professional duty of care for individual patients. It is
argued that such a responsibility is not undermined
where none of the treatments are felt to be a superior
option for the patient. In other words there is neither
advantage nor disadvantage to the patient in either
selecting a treatment or having their treatment randomly
allocated [26, 27]:
‘Equipoise is the point where we are equally poised in
our beliefs between the benefits and disadvantages of
a certain treatment modality. … At this point we are
agnostic or resting on the fulcrum of a preference.’
(Johnson et al. 1991: p. 30 in [28])
‘Individual equipoise’ (or ‘theoretical equipoise’) is
where an individual clinician is balanced in their opinion
of the available treatments. ‘Collective equipoise’ (or
‘community equipoise’) is where there is no consensus
among the profession as a whole [25, 27–29]. Collective
equipoise is the basis from which individual clinicians
are often urged to put aside personal opinions and
accept the collective uncertainty of their peers in order
to recruit to a trial [27, 29].
Equipoise is often discussed in terms of adequate or
sufficient uncertainty; however, it is important not to
confuse this with a lack of knowledge [30]. There is
often extensive evidence as to the safety and effectiveness
of trial arms. The key aspect of equipoise is that, given the
current evidence, there is an equilibrium between the
alternatives [28]. Establishing this uncertainty in practice
can be very difficult. Consider, for example, that most con-
temporary trials do not involve like-for-like outcomes,
such as the eradication of a cancer, but multiple outcomes,
such as quality of life measures or recovery time. Lilford
and Jackson helpfully distinguish ‘absolute equipoise’, in
which a treatment is either better or worse, with the more
common ‘effective equipoise’, in which there exists a
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trade-off between multiple outcome measures [29]. Many
contemporary trials, like the OPEN trial discussed in this
article, involve effective equipoise in which the balance
between treatments involves a trade-off between known
differences in the treatments.
Within trial literature the concept of equipoise has
been discussed almost exclusively from the perspective
of professionals and the medical community (the ‘we’ in
the Johnson et al. quote above, is referring to profes-
sionals). The literature on shared decision-making and
equipoise tends to focus on how best to communicate
clinical or collective equipoise to a patient, rather than on
whether patients themselves are in equipoise [10, 27, 30].
However, the idea of being fully informed yet poised
between alternative treatments is entirely applicable to pa-
tients’ decision-making. Ethical trial recruitment requires
that patients are informed yet have no preference between
treatments [31]. The prominence of clinical rather than
patient equipoise in the trial literature is a reflection of
how the field developed within highly clinical, often
oncological, trials which presuppose a particular form
of patient-professional relationship, where the profes-
sional has specialist knowledge and the patient is re-
quired to accept equipoise by proxy [31]:
‘In theory a patient who gives informed and voluntary
consent to enter a randomised trial has achieved the
equilibrium of equipoise. In practice equipoise
among patients ranges from personal to proxy.’
(Alderson, 1996: p. 135 in [31]).
However, there is no need for equipoise by proxy
where the necessary information is easily communicated
and understood by patients, as they would be able to
reach personal equipoise themselves. With regards to
recruitment, trialists often work on the basis that pa-
tients are most amenable to participation when they ad-
equately comprehend clinical equipoise. What has not
yet been explored, to the best of our knowledge, is how
patients’ equipoise may encompass value-driven factors
that differ from the evidence-based clinical uncertain-
ties of the trial. Neither has it been considered that the
patient population, like the professional community,
may have collective equipoise. In this paper we use the
concept of equipoise to understand patients’ decisions
about whether or not to participate in the trial.
The OPEN trial
Bulbar urethral stricture is a narrowing of the urethra
caused by scar tissue and is a common cause of urinary
difficulties in men. The OPEN trial compares the effective-
ness of two surgical interventions: urethrotomy and ure-
throplasty. Urethrotomy is a relatively straightforward
operation in which the scar is incised using an endoscope
passed down the urethra. However, the scar tissue and
urinary difficulties often recur typically within 2 years.
Urethroplasty is a more invasive operation which involves
reconstructing the urethral tube through a skin incision
between the legs and using graft tissue taken from inside
the mouth. The OPEN trial has established urological
centres across the UK to randomise men with recurrent
urethral stricture between these two surgical interven-
tions. The eligibility criteria is to be 16 years or older with
no upper age limit. Men must have a bulbar urethral stric-
ture and have undergone at least one previous interven-
tion for the stricture. However, there are no exclusion
criteria for the severity of symptoms.
Accrual for the OPEN trial faces particular challenges
that require investigation. Participants must be willing to
have their intervention allocated at random. Further-
more, the treatment options differ in invasiveness and
the duration of postoperative bladder catheterisation.
The relatively low prevalence of recurrent urethral stric-
ture entails the need for multiple recruitment sites
across the UK, leading to variation in recruitment prac-
tices and resources as well as clinician bias [1]. Lastly,
men with the condition often prefer to self-manage and
conceal symptoms rather than seek curative treatment
[32]. To explore these challenges, the OPEN trial employed
a nested qualitative study, interviewing both patients and
clinicians to better understand and inform feasibility of the
recruitment process.
Methods
Interviews were with 19 men who were eligible for par-
ticipation in the OPEN trial and 15 urologists seeing and
treating men with urethral stricture. Patients were
approached about trial and qualitative study participa-
tion during their treatment decision-making at urology
sites across the UK. At the close of the qualitative com-
ponent, 25% (40/159) of those screened for trial partici-
pation said that they would be willing to take part in an
interview. To be eligible for the trial, a patient will have
had one previous intervention for urethral stricture; all
those interviewed had, therefore, undergone previous
stricture surgery but their symptoms had returned. The
researcher (PW) contacted all those who were willing to
be interviewed. Following ethics approval (reference:
12/NE/0343) and individual informed consent, semi-
structured interviews explored men’s experience of the
disease, their treatment preferences and their experience
of trial recruitment. Of the 19 patients interviewed, 9 men
had also consented to treatment randomisation and 10
had declined full trial participation.
Fifteen clinicians were also recruited from a list of
practicing urologists in the UK and included some who
were recruiting to the trial (n = 9) and others who were
either not involved (n = 2) or who were considering
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participation (n = 6). The researcher (PW) contacted cli-
nicians by telephone or email and conducted the audio-
recorded interviews either face-to-face or by telephone.
Recordings were transcribed verbatim, anonymised, then
coded and analysed following the broad principles of
thematic analysis [33, 34]. Analysis was undertaken
alongside data collection, so analysis of prior interviews
informed both the sampling decisions and interview
questions. We used Qualitative Data Analysis (QDA)
software to support the management and retrieval of
data [35], as well as writing analytic memos and using
tables, process maps, and diagrams to further explore
and refine emergent issues [34]. Analysis was also sup-
ported by discussion of anonymised transcripts in trial
meetings and regular qualitative data clinic sessions,
which included health professionals and social scientists
from a range of clinical and academic backgrounds.
Results
The findings are reported in three sections: Patient
preference, Clinicians’ perspectives and Organisation of
care and trial recruitment. The purpose is to illustrate
how the qualitative investigation improved our under-
standing of patient preference and clinician practice, and
how these could be mapped to the existing trial design.
Patient preference
Nineteen men, ranging in age between 25 and 70 years
old (median = 36), were recruited from five urological
clinics. Most of the men interviewed had had one or two
previous urethrotomies, three had had three or more re-
peat urethrotomies. Bulbar urethral stricture is a benign
urological condition that significantly impacts on men’s
lives. The main symptoms are frequent and prolonged
visits to the toilet that mean waking during the night,
disruption to work and social life, and the threat of
social embarrassment [32]. The patients interviewed
were sympathetic to the purpose of the trial, although,
as with other trials, often declined participation because
of an overriding preference for one option.
Preference for urethrotomy
Those men who expressed a preference for urethrotomy
said that it was to avoid wearing a catheter, taking time
off work or undergoing the ‘serious’ operation necessary
for urethroplasty:
‘I didn’t fancy losing 3 months, 4 months off work,
couldn’t afford to.’ (Patient, declined)
‘You’re going to be in hospital for a couple of days
you have the catheter in for over 10 days or what not.
It’s kind of, no it’s freaked me out a little bit. I’m quite
happy with urethrotomy.’ (Patient, declined)
The shorter recovery period and minimum disruption
to their work and lifestyle appealed to them and could
be underpinned by the private nature of the condition.
Concealment, particular to conditions such as bulbar
urethral stricture, reinforces the tendency to avoid time
off work or wearing a catheter [32].
Patients were aware of the trade-off between repeated
treatments versus the possibility of a permanent solution:
‘Nobody really fancies surgery but [the clinician] says
I should have [urethroplasty] done and I said, “well I
will next time and I will make the time for it”. I’ll have
to because if you add up all the time I’ve had for
[urethrotomy] that I’ve lost I could have been sorted
by now.’ (Patient, declined)
Bulbar urethral stricture, although a significant burden
on men’s lives, is a benign condition that lacks the sense of
fear and immediacy that other patients might experience
with conditions such as cancer. This means that these men
could reasonably opt for the ‘short-term solution’ of ure-
throtomy and potentially delay curative treatments:
‘The operation I’ve already had, I’m quite happy
with that until it’s really necessary to move on.’
(Patient, declined)
Delaying a more serious operation (urethroplasty) until
‘moving on’ is necessary or unavoidable, was a common
justification for having a preference for urethrotomy:
‘I don’t think I could go through that operation
unless anything drastic happened [yeah] where I
really feel, you know, the pain was getting too much.’
(Patient, declined)
Preference for urethroplasty
Other interviewees declined randomisation due to an
overriding preference for urethroplasty. The common
account of these patients is that they are seeking a cura-
tive solution because the symptoms and recurrence, des-
pite previous urethrotomy, were no longer tolerable. For
these patients being randomised to another urethrotomy
was not acceptable:
‘I’ve tried that and it didn’t work, why would I do it
again?’ (Patient, declined)
Some of these men who were actively seeking an al-
ternative to urethrotomy, had been referred for that
purpose and had travelled some distance to see a ure-
throplasty specialist. These patients saw themselves as
being at a point in which urethrotomy was not an ac-
ceptable treatment option. As the following extract
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illustrates, they can be understood as being past the
point of equipoise:
‘I don’t see the sense in sitting here in 6 months’ time
going in for regular dilation because, you know, there
has to come an end to it somewhere. So that’s the
route I went down. And I said [to the consultant],
“look you know, I’m very happy to help in any way
that I can [with the trial] but, eh, I’d rather go for the
sort of bigger op on the basis that there’s a good
chance that will sort it out and make life more
comfortable for a longer period of time”. And that’s
where I’m at.’ (Patient, declined)
A key detail is the idea of being at a specific point, or
as this participant said ‘that’s where I’m at’. This is rep-
resentative of other accounts of declining trial participa-
tion due to a preference for urethroplasty. It should be
noted that there was no particular number of previous
urethrotomies that helped to frame the decision: some
were unwilling to have a second, others were willing to
receive a third or fourth.
Accepted randomisation
The nine men interviewed who accepted randomisation
described being at a point in which the difference in cost
and benefits of each treatment were negligible. Three
expressed a weak preference but were still willing to
‘help out’. The other six said that, given the evidence,
they were undecided which treatment would be best for
them at that point in time. These patients can be under-
stood as being at a point of equipoise as they are in-
formed, having weighed the comparative costs and
benefits of the two alternative treatments, yet have no
strong preference. They are, with the current informa-
tion they have to hand, agnostic, or equally poised, between
the desire for a shorter recovery time and the possibility of
a curative solution:
‘[With urethroplasty] I’m not so worried about the
catheter. I would take the time off and just sit that
out […] But it’s, obviously, [worrying] that you will
make a full recovery afterwards and you won’t be
having to look after your wounds forever, essentially.
That’s the worry on that. [Consultant] got a very good
reputation for this sort of thing. So it’s not this
actual procedure that bothers me, it’s the recovery
afterwards and affecting your ability in later life. […]
As for concerns about the urethrotomy, my main
concern with that is that I don’t want to keep having
that every 2 years. It was a relatively painless
operation. I was in and out during the same day. But I
don’t want to keep going back every 2 years or so to
have that repeatedly done.’ (Patient, randomised)
This patient decided to have his treatment randomised
and is a good example of a point of equipoise within the
OPEN trial. Having had two previous urethrotomies, he
was willing to have another but also ready to try the more
invasive alternative. The man describes being worried
both about recovering from urethroplasty and needing re-
peat surgery, which are the uncertainties underpinning
the OPEN trial. This balance of factors illustrates the
necessary uncertainty for accepting random treatment
allocation and trial participation. Interestingly, however,
the same patient commented that, were there to be a next
time, he would no longer be indifferent:
I: ‘Would you feel disappointed at all if you were
randomised to the urethrotomy?’
R: ‘I’m not disappointed at this stage, no. I think,
obviously, the next time, I would probably be heavily
in favour of the other.’ (Patient, randomised)
Such accounts suggest a particular window of opportunity
in which men with recurrent bulbar urethral stricture are in
equipoise and willing to accept randomisation.
Patients’ balanced the immediate inconvenience of a
long recovery period with better chances of a curative
solution. Table 1 illustrates how treatment decisions
were closely related to patients’ perception of the sever-
ity and manageability of their symptoms. Those with an
overriding preference understood their own urethral
stricture symptoms to be at a particular point: either too
slight to consider a serious operation or too severe not to.
Table 1 Summary of patients’ accounts of their treat preferences
Decision Preference Symptoms Operation
Declined randomisation Preference for urethrotomy Symptom recurrence and severity is tolerable Symptom recurrence sufficiently tolerable
to not want to endure serious operation
and recovery time
Preference for urethroplasty Symptom recurrence and severity no longer
tolerable. Patient desires a permanent solution
Desire for long-term solution overrides
immediate symptom relief. Unwilling to
risk further recurrence
Accepted randomisation No preference Symptoms tolerable but considering
serious operation
Willing to commit to recovery time.
An additional repeated urethrotomy is
also acceptable
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An important contribution of the feasibility qualitative
study is to highlight how equipoise happens within par-
ticular margins of symptom severity and manageability.
Clinicians’ perspectives
The OPEN trial is multicentre with participating urology
clinics across the UK. Fifteen clinicians from 15 sites
were interviewed in order to better understand their
perception of the trial and recruitment practices. Their
years of experience range broadly from 4 to more than
30 years. Some clinicians reported common concerns
around time constraints, resourcing and questions re-
garding patient eligibility. All clinicians were supportive
of the OPEN trial and felt that it would answer a valu-
able clinical question. An important distinction to make
at this juncture is that there are two types of clinicians
participating in the trial: specialist urologists and general
urologists. Specialists are able to offer both of the OPEN
trial treatment options as they are trained to carry out
urethroplasty, whereas general urologists are only able
to deliver urethrotomy and would refer patients to a
specialist if they feel that urethroplasty is required. A
key finding, and purpose of this section, is that general
and specialist urologists differed in their approach to
recruitment.
General urologists
Most general urologists anticipated that eligible patients
would prefer urethrotomy and that this would be a
barrier to recruitment. General urologists’ accounts
presented this as the ‘easy’ option that patients would
‘obviously’ prefer:
‘If you give the patient the option of having an
endoscopic procedure where he goes home the
same day versus being referred to another unit
somewhere else for an open surgical procedure then
obviously patients might go for the easier option.’
(General urologist)
‘Most patients are going to opt for a urethrotomy
and not a urethroplasty but you can either have day
case operation and go home with a catheter for a day
or two or you can have a major procedure and be in
hospital for a few days and I think it’s just going to be
hard: why would I want to be randomised, I’d rather
just have the easy one.’ (General urologist)
These expectations were related to ideas about the
average types of eligible patient. General urologists
described men with recurrent stricture as being older
or with relatively minor symptoms. These men were
typically treated by repeated urethrotomies and self-
management using the adjunctive technique of intermittent
self-dilatation (ISD). Putting these patients forward for
randomisation would be challenging:
‘I think the work [of the OPEN trial] needs doing, it’s
a good study to do. I think we will have a few issues
with people opting to have an operation that we may
not have recommended in the normal situation.’
(General urologist)
Although eligible, randomising these patients proved
difficult when at odds with their routine clinical practice.
The following quote suggests a blurred line between
what the ‘old guys’ want and what the general urologist
is comfortable offering:
‘There are few guys, old guys, who really don’t
want to have an urethroplasty that keep getting
urethrotomy. You know most of them, after I have
seen them, will go with the urethrotomy and then
send him home generally.’ (General urologist)
The perceived expectations of the ‘older patients’ or
those with ‘relatively minor symptoms’ underlie the
clinician’s temptation to be selective in identifying po-
tential participants:
‘If somebody has a very simple urethral stricture and
then you will think “oh, why should I subject this
person to an open procedure rather than just an
optical urethrotomy?”’ (General urologist)
‘I think we do treat the different age groups slightly
differently so the young guys are more likely to go for
a urethroplasty […] whereas your elderly guy, you’re
trying to avoid operations, […] I think there is a lot
of individual basis that we are going to make these
decisions on.’ (General urologist)
Uneven representation of the treatment arms can be
seen to be an extension of what the clinician felt that
their patients wanted or needed. The perceived expect-
ation of the ‘typical’ patient with recurrent stricture led
to a tendency to recommend urethrotomy:
‘Patients who would like to take the chance
[with urethroplasty] if you tell them that with the
urethrotomy there is a certain chance that you’ll
be fine you won’t need the reconstruction so they
might go for that’. (General urologist)
The findings of the qualitative study, therefore, highlight
a preference, a selection bias, of general urologists (See
Table 2). However, it is important to note how this
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preference is underpinned by consideration of patients
who tends to be older or with relatively minor symptoms.
Specialist urological surgeons
Specialist clinicians anticipated the opposite: that few pa-
tients would be willing to consider another urethrotomy
and that overriding preference for urethroplasty would be
a barrier to recruitment (see Table 2):
‘I would imagine for somebody who’s had two
urethrotomies, of average – of typical age, probably
75% of them definitely are happy to proceed to the
urethroplasty.’ (Specialist urological surgeon)
Specialists see a large proportion of referrals with either se-
vere or complicated strictures referred specifically with the
intention of discussing urethroplasty as a treatment option:
‘One of [my] concerns with the OPEN trial is that the
guys I’m seeing are generally those who have been
referred to me with a view to doing an urethroplasty.’
(Specialist urological surgeon)
‘They may have already had two or three
urethrotomies and now they are referring
them on with a view to a urethroplasty.’
(Specialist urological surgeon)
Specialists found it hard ‘selling’ the trial to patients
and felt compelled to guide them towards urethroplasty,
especially cases that were severe or complex. Here, a
specialist describes an encounter with a man who has
been tolerating severe symptoms:
‘He said, “oh that’s about normal (!)”. I said,
“well if I told you that was less than 10% of the flow
of a normal person and that you’re leaving behind
more than half a bladder full of urine, how would you
react to that?” And he said, “oh that’s terrible!” I said,
“yes, well you really should have an [urethroplasty]
operation!”’ (Specialist urological surgeon)
In this case, despite the patient’s eligibility and uncer-
tainty, the surgeon could not remain neutral and was
compelled to recommend urethroplasty. Such accounts
are evidence of a lack of clinical equipoise at the limits
of the eligibility criteria [10, 27]. Many specialists
described the difficulty in staying neutral. Even if they
would not explicitly recommend urethroplasty, they re-
ported producing language and terminology represent-
ing treatment arms unevenly:
‘If you say to them you can have a more complicated
operation you’ve got a 95% chance of being cured versus
we can keep doing this [urethrotomy] every couple of
years and you’ll end up urethral cripple, most of them
will take the option [of urethroplasty].’ (Specialist
urological surgeon)
The eligibility criteria for the OPEN trial has no upper
age limit. Neither is the severity of the stricture symptoms
a reason for exclusion from the study. However, interviews
reveal how, in practice, this can be grounds for selectivity in
approaching patients. Previous nested qualitative studies
have highlighted clinician ‘selection bias’ as a distinct barrier
to recruitment. Similarly, our result found that despite sup-
porting the trial, general and specialist urological surgeons
admitted to only discussing the trial with certain types of
patient, or struggling to represent the arms of the trial
evenly. These findings highlight the need for training to
support and promote more standardised recruitment prac-
tices across participating sites [36]. However, the difference
between general and specialists invites a closer look at how
the trial is integrated with the organisation of care.
Organisation of care and trial recruitment
The OPEN trial qualitative feasibility study found evi-
dence that patient preference and clinician ‘selection
bias’ are potential barriers to trial recruitment. As with
previous trials, it is important to engage with these
issues through such actions as improved patient infor-
mation and recruiter training [36]. The findings also
illustrate how patients may have a particular window in
which they are in equipoise and that clinical selection
bias reflects differences in general and specialist practice.
In this section we map these findings onto the organisa-
tion of stricture patient care and trial recruitment de-
sign. Patients reported changes to their preferences and
anticipated changing their preference in the future. This
illustrates how preferences are dynamic and have a tem-
poral dimension. Those who opted for urethrotomy felt
that it was too soon to consider the alternative and those
who opted for urethroplasty felt that it was too late not
to. So although preference between individual stricture
Table 2 Comparison of trialists’ expectations and recruitment practices
Trialist Patient population Clinicians’ expectations Recruitment practice
General urologist Older, history of self-management and urethrotomy Patients will opt for urethrotomy Older patients excluded, reluctance to refer
Specialist
urologist
Younger, complex referrals Patients will opt for
urethroplasty
Reluctance to suggest a repeat
urethrotomy
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patients differed, there exists a common trajectory
underpinning these decisions. Patients in equipoise de-
scribed being at a particular point in which differences
in cost and benefit of each operations were negligible.
Once these men seek help they will typically be referred
by a general practitioner to a urological clinic. At this point
a lot depends on geographical location; the majority will go
to their nearest general urological clinic while others go to
a specialist centre. In the first instance, urethral stricture
patients are most likely to be offered a urethrotomy. Many
of these patients will experience symptom recurrence
anywhere between 3 months to several years and will return
to the clinic to discuss further treatment. This is the point
at which the patient is eligible take part in the OPEN trial.
Taken alongside clinicians’ accounts, this suggests that
the population of eligible urethral stricture patients is
unevenly represented between general and specialist sites.
General urologists have a higher proportion of stricture
patients receiving repeated urethrotomy treatments, either
because their symptoms are relatively minor and tolerable,
or because they wish to avoid a serious operation or
travelling to a specialist. Specialists are more likely to
encounter patients considering urethroplasty and who may
have been referred for that purpose.
At the onset of the OPEN trial recruitment (spring 2013)
all patients were being recruited from specialist centres.
This made practical and organisational sense: consultants
involved in setting up the trial were based at these sites and
were able to deliver both treatment arms. However, the
qualitative findings illustrate how patients approached at
this point tended to be ready for urethroplasty and are,
therefore, not in equipoise. Patients reported a common
trajectory of worsening symptoms underpinning their deci-
sion about trial participation. What was needed was to re-
cruit patients earlier in their treatment pathways, before
specialist referral, when their symptoms are tolerable
enough to consider a repeat urethrotomy. One way to do
this, and part of the recommendations of the feasibility
study, was to increase involvement of the general urology
sites to capture patients earlier in their condition.
Discussion
The aim of the OPEN trial is to establish the relative benefit
and cost-benefit of urethroplasty and urethrotomy over 2
years for treating men with recurrent bulbar urethral
stricture. Urethral strictures can be treated either with a
urethrotomy, which is essentially a symptom palliation
procedure, or the more time-consuming and invasive
urethroplasty, which may be a curative solution. In order to
participate in the OPEN trial, patients need to be equally
poised in their belief about the relative benefits and disad-
vantages of each treatment.
Timing of approach
The results highlight how patients’ decisions to accept
or decline randomisation were situated within the
overall trajectory of their illness and treatment. Gen-
erally, the longer a patient has had a urethral stric-
ture, the more likely it is that their symptoms will
return and the more likely they are to want to com-
mit the time necessary for the possible curative solu-
tion promised by urethroplasty (see Table 1). Patients
who felt that their symptoms were tolerable were less
likely to commit to the recovery time and more likely to
opt for urethrotomy. Therefore, patient preference can be
understood within the context of a stricture patient’s
common trajectory of worsening symptoms. There was a
particular window of opportunity in which patients were
willing to accept either procedure. The OPEN trial initially
relied on approaching patients at specialist sites. However,
Fig. 1 An epidemiological characteristic of equipoise: points of recruitment capture different proportions of the patient population
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this was misaligned with the point at which the patients
were most likely to be in equipoise (Fig. 1). Following the
feasibility study, the OPEN trial has opened more general
centres in order to capture patients earlier in their illness
trajectory. This change to recruitment practice had the
desired improvement to recruitment. General site
recruited at an average of 30% of screened patients
compared to 27% in the specialist centres. However,
setting up the additional sites was resource-intensive for
the trial team.
Clinical and collective equipoise
The qualitative interviews with clinicians found,
similarly to other trials, inconsistent recruitment
practices, selectivity and conflicts between trial re-
cruitment and local clinical practice. This was to be
expected as recruiting to a clinical trial is known to
be emotionally and intellectually challenging, espe-
cially where it conflicts with routine clinical judge-
ments [10]. Recruiters often struggle to offer trial
participation with patients on the limits of eligibility
[10, 27], such as extreme ranges of age or symptom
severity. A unique finding within this study is the dif-
ference in clinical bias between general and specialist
sites. Specialist urologists were reluctant to randomise
patients whose symptoms were severe, while general
urologists found it difficult to refer patients’ whose
symptoms were manageable with a repeat urethrot-
omy. These differing perspectives correspond with
the types of stricture patient they typically treat.
General urologists see patients with moderate symp-
toms while specialists see more complex and severe
cases (see Table 2).
We suggest that the difficulty that recruiters have in
achieving clinical equipoise is not adequately explained
as individual bias, but is partially an outcome of their
relative position in the organisation and division of
urethral stricture care. As the eligibility criteria for the
trial includes patients with moderate and severe symp-
toms, the target population is unevenly distributed be-
tween sites. As a whole, the urological profession
achieves collective equipoise. However, individual re-
cruiters may struggle to align their practice with clinical
equipoise when they manage a particular proportion of
the patient population (see Table 2).
These findings add to the evidence that recruiting
to a clinical trial is highly challenging and the import-
ance of training to help clinicians overcome individual
bias and communicate the delicate issue of collective
equipoise [22, 27, 36]. Furthermore, we suggest that
the difficulties faced were differentiated and reflect
the structural and organisational contexts of clini-
cians’ practice. Understanding these perspectives can
help to develop effective and targeted training and
other recruitment interventions.
Patient population and equipoise
In this research we used both patients’ and clinicians’
accounts to understand how patients’ experiences map
onto the point at which patients are approached about
the trial. Patients’ decision about whether or not to par-
ticipate in the OPEN trial were understood within an ex-
pected trajectory of worsening symptoms. Patients who
declined participation either felt that their condition was
too slight to consider a serious operation or too severe
not to. Patients who agreed to randomisation described
being at a particular point in time when the relative cost
and benefits of each procedure where negligible.
The concept of equipoise, as informed uncertainty,
can be applied to patients’ decision about trial participa-
tion. Those patients who were willing to be randomised
were at a point in their condition where the advantages
or disadvantages of recovery time or of repeat surgery
were equivalent. The findings suggest that treatment
preferences were dependent on how serious or intoler-
able the patients felt their condition to be. Although
these factors are balanced from the perspective of the
urological community, they may be considerably uneven
for an individual patient who values recovery or a
curative solution above all else. Patients declining trial
participation were not just expressing a preference, they
were making informed decisions based on how the
known trade-off between the procedures relates to their
relative condition. In this sense the point of patient
equipoise can be understood within the context of the
experiences of the broader population of stricture pa-
tients (Fig. 1).
While not all trials will involve patient equipoise re-
lated to a trajectory of worsening symptoms, they
may involve patient equipoise relative to other factors
of the target population such as gender [37, 38],
behavioural change [39] educational level [40] or pa-
tient involvement [41]. The specific nature of these
factors is dependent on the particularities of the trial,
the patient population and the interventions being
compared. Qualitative research can be used to better
understand a target patient population and reasons for
patients having uncertainty between treatments, particu-
larly where these depart from the conditions of clinical
equipoise.
Qualitative research and trial recruitment
A number of methods have been suggested to overcome
the ‘problem’ of patient preference. Statistical techniques
can adjust for patient preference [42] or clinician biases
[43], although they risk confounding results [42]. Patient
preference trials or recruiting from cohorts also sidestep
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the issue as these can only compliment rather than
replace the ‘(gold) standard’ of randomisation [44].
Qualitative research embedded within trials has emerged
as the most promising approach to improving recruit-
ment [4] by, for example, successfully helping clinicians
to better engage with patients [10]. Qualitative data re-
quires careful application by development of explanatory
accounts using sets of analytical techniques [45]. There
has been a tendency to over-simplify qualitative research
and reifying ‘patient preference’ into a linear ‘barrier’ to
be overcome. For example, saying that patients’ self-
completed questionnaires will ‘establish recruitment bar-
riers’ by avoiding ‘interviewer bias’ [46], which implicitly
assumes that patients are best placed to directly answer
recruitment problems. Similarly, others refer to inter-
viewing clinicians as problematic because it is an indirect
way to gain access to patient opinions [47, 48]. These ap-
proaches are limited because they reduce the role of quali-
tative research to simply canvassing opinions. In contrast,
interviewing clinicians may be crucial for understanding
the range of patients typically seen and the context of invi-
tations to participate. Interviewing patients is helpful in
understanding their lived experience or reasons for
decision-making. Such research works best when it is
theoretically informed and used to develop explanatory
accounts of that patient group.
In their work of reviewing and categorising qualitative
research within trials, O’Cathain et al. found that trialists
rarely had a good rationale for employing qualitative
studies and urge that embedded qualitative methods
should be more explicit and directed [7]. We hope to
have contributed to this discussion, suggesting that one
way in which to guide qualitative studies within trials is
to overtly explore and elucidate key factors underpin-
ning treatment preferences and equipoise. We recom-
mend thinking about patient equipoise as potentially
involving values external to those of the trial and how
these may impact on the possibilities for recruitment.
Conclusion
The findings of the OPEN trial qualitative study are
comparable to those of other recruitment investigations
in finding that patient preference and clinician selection
bias are significant in limiting trial recruitment. The
particular value of these findings for the OPEN trial has
been in showing how and why these differ between site
types. Stricture patients are unevenly represented between
points of recruitment. Patients with the sufficient uncer-
tainty to be in equipoise were approached at the appropri-
ate point in their illness trajectory when neither treatment
was felt to be superior. General and specialist clinicians
had different expectations of patients and can be seen to
struggle to align their practices with the collective
equipoise of the trial. The implication of these findings for
the OPEN trial was to recruit patients earlier in the refer-
ral process by enrolling more general urology sites, and to
develop differentiated, targeted recruitment training for
general and specialist urologists.
We have suggested that patient and clinician preference,
often discussed as ‘barriers’ to recruitment, are often an
artefact of the organisation of care and the point at which
patients are approached. Qualitative feasibility studies can
be used to better understand the target population prior
to recruitment in order to optimise the point of ap-
proaching patients. The conditions of patient preference
and equipoise are likely be contingent on values other
than those of collective equipoise underpinning the trial.
Articulating these findings requires an epidemiological
approach to the concept of equipoise, situating it as a
measurable characteristic of a target patient group.
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